X-ZELL Cryoimmunostaining™ Suite to feature at Medlab Asia 2019
Singapore, February 2019 – Singaporean medical technology start-up X-ZELL will preview the production version of the world’s first slide-based, eight-channel immunostaining solution at the 2019 Medlab Asia Pacific trade show, to be held at Singapore’s Suntec Convention Centre from 26-18 March.
Originally designed to enable the company’s headline-making research into next-generation biomarkers, the Cryoimmunostaining™ Suite consists of two high-performance devices, the CryoFixator™ and the CryoStainer™, which enable researchers to apply up to eight biomarkers* at a time to cells fixated on standard laboratory slides – making it one of the most powerful cytology tools in the world.
“We have had tremendous success using our Cryoimmunostaining™ technology as part of our own research over the past two years,” said X-ZELL CEO, Dr Sebastian Bhakdi – explaining the system serves as the gateway to next generation, eight-colour fluorescence microscopy, a breakthrough technique he invented and published in 2018.
“Eight-colour immunostaining has not only enabled us to detect a new type of circulating cell that had previously been considered undetectable in clinical routine, but also allowed us to develop liquid biopsies that can reliable detect clinically significant prostate cancer at the earliest stages.
“We believe now is the time to start sharing next-generation single-cell immunofluorescence cytology with the rest of the world.”
To book an appointment with an X-ZELL representative at the 2019 Medlab Asia Pacific trade show, please contact email@example.com.
For media and interview enquiries, please contact firstname.lastname@example.org.
*X-ZELL’s Cryoimmunostaining™ Suite has been validated for multiplexing up to 8 different fluorophores to enable the fast and direct visualization and characterization of membrane, cytosolic and nuclear antigen expression in single cells as well as organ tissue – all with minimal crosstalk between fluorescence channels and no downstream application of advanced mathematical algorithms.
Head of Marketing & Communications